Marc Tessier-Lavigne

Affiliations

  • Director at Denali Therapeutics Inc. (DNLI), 2024-06-04
  • Director at Regeneron Pharmaceuticals Inc. (REGN), 2023-01-05
  • Director at Agios Pharmaceuticals Inc (AGIO), 2016-06-23
  • Director at Juno Therapeutics Inc. (JUNO), 2016-06-21
  • Director at Pfizer Inc (PFE), 2015-04-24
  • Officer at Genentech Inc (DNA), 2009-03-30
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AGIO $18.00 55,555 Director 101,009 2013-07-24 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
DNLI $30.48 20,000 Director 1,870,356 2022-11-23 Filing
DNLI $30.33 11,252 Director 1,890,356 2022-11-02 Filing
DNLI $30.20 8,748 Director 1,901,608 2022-11-01 Filing
REGN $718.00 3,612 Director 2,269 2022-10-03 Filing
REGN $698.00 3,428 Director 2,269 2022-09-30 Filing